Skip to main content
  • Image

Synsiro® Pro

Drug-Eluting Stent System

The Synsiro® Pro Sirolimus-Eluting Coronary Stent System is a drug-eluting balloon-expandable stent pre-mounted on a rapid-exchange PTCA catheter delivery system. 

(Only available in selected countries)

Category

Vascular Intervention Coronary

Product Highlights

Image

The next level of deliverability1

Image

Ultrathin struts2

Image

Outstanding patient outcomes3

Technical Data

Stent  
Stent material Cobalt chromium, L-605
Strut thickness ø 2.25 – 3.0 mm: 60 µm (0.0024”);

ø 3.50 – 4.0 mm: 80 µm (0.0031”)
Passive coating proBIO® (Amorphous Silicon Carbide)
Active coating BIOlute® bioabsorbable Poly-L-Lactide (PLLA) eluting a limus drug
Drug dose 1.4 µg/mm²
Delivery System  
Catheter type Rapid exchange
Recommended guide catheter 5F (min. I.D. 0.056”)
Guide wire diameter 0.014”
Usable catheter length 140 cm
Balloon material Semi crystalline polymer material
Coating (Distal shaft) Hydrophilic
Coating (Proximal shaft) Hydrophobic
Marker bands Two swaged platinum-iridium markers
Lesion entry profile 0.017”
Distal shaft diameter 2.7F: ø 2.25 – 3.0 mm; 2.9F: ø 3.5 – 4.0 mm
Proximal shaft diameter 2.0F
Nominal pressure (NP) 10 atm
Rated burst pressure (RBP) 16 atm
Storage  
Use Before Date (UBD) 24 months
Temperature Between 15°C (59°F) and 25°C (77°F), short term excursions between 10°C (50°F) and 40°C (104°F) are allowed

Ordering Information

Stent

ø (mm)
Stent Length

(mm)
  9 13 15 18 22 26 30 35 40
2.25 419155 419161 419167 419173 419179 419185 419191 419197 419203
2.5 419156 419162 419168 419174 419180 419186 419192 419198 419204
2.75 419157 419163 419169 419175 419181 419187 419193 419199 419205
3 419158 419164 419170 419176 419182 419188 419194 419200 419206
3.5 419159 419165 419171 419177 419183 419189 419195 419201 419207
4 419160 419166 419172 419178 419184 419190 419196 419202 419208

How can we help you?

I prefer to be contacted by
*Fields are mandatory.

References

1. In comparison to Xience Sierra, Resolute Onyx and Synergy for bench tests on pushability, trackability and crossability, BIOTRONIK data on file; 2. As characterized with respect to strut thickness in Bangalore et al. Meta-analysis; 3. Based on investigator’s interpretation of BIOFLOW-V primary endpoint result.

Clinical data collected with Orsiro, Orsiro Mission’s predecessor device can be used to illustrate Synsiro Pro clinical outcomes.

Synsiro, proBIO and BIOlute are trademarks or registered trademarks of the BIOTRONIK Group of Companies.

Only available in selected countries.